Accessibility Statement Skip Navigation
  • Resources
  • Data Privacy
  • Contact Us
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • All Multimedia

        • All Multimedia
        • All Photos
        • All Videos
    • Business & Money
        • Auto & Transportation

        • Aerospace & Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads & Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking & Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Accessories
        • Computer Hardware
        • Computer Networks
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High-Tech Security
        • Internet Technology
        • Nanotechnology
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art, Culture & Design
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers & Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Projections or Forecasts
        • Financing Agreements
        • Insurance
        • Joint Ventures
        • Mutual Funds
        • Offerings
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing/marketing agreements
        • New Products & Services
        • Obituary
        • Outsourcing Businesses
        • Overseas Real Estate (Non-US)
        • Personnel Announcements
        • Residential Real Estate
        • Small-Business Services
        • Socially Responsible Investing
        • Surveys, Polls & Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Accessories
        • Computer Electronics
        • Computer Hardware
        • Computer Networks
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Design Automation
        • Financial Technology
        • Mobile Devices/Apps
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Natural Gas Utilities
        • Oil & Energy
        • Oil & Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation & Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking & Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Computer Accessories
        • Computer Networks
        • Mobile Devices/Apps
        • Telecommunications
        • Telecommunications Carriers & Services
        • Telecommunications Equipment
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wine & Spirits
        • Beverages
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food
        • Furniture & Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art, Culture & Design
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infectious Disease Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks & Tourist Attractions
        • Gambling & Casinos
        • Hotels & Resorts
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Animal Welfare
        • Corporate Social Responsibility
        • Economic News, Trends & Analysis
        • Education
        • Environmental Products & Services
        • European Government
        • Natural Disasters
        • Not-for-Profit
        • Public Safety
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Children-related news
        • Disabled Persons
        • Diversity, Equity & Inclusion
        • Hispanic-oriented news
        • LGBTQ+
        • Religion
        • Senior Citizens
        • Veterans
        • Women-Related news
        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Request a Demo
    • Partnerships
    • Media Inquiries
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring Home
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us


    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • News Releases
      • Send a Release
      • Data Privacy
      • 2 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • News Releases
      • Send a Release
      • Data Privacy
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • News Releases
      • Send a Release
      • Data Privacy
      • General Inquiries
      • Request a Demo
      • Partnerships
      • Media Inquiries
      • Editorial Bureaus
      • News Releases
      • Send a Release
      • Data Privacy
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • All Multimedia
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Regenerative Aesthetics brand LÖVISELLE Launches at National Gallery Singapore, Under the Theme "Beyond Stimulation, True Regeneration"


      News provided by

      Löviselle

      20 Nov, 2026, 10:05 CST

      Share this article

      Share this article


      SINGAPORE, Nov. 19, 2026 /PRNewswire/ -- LÖVISELLE, a regenerative medical aesthetics brand, celebrated its official Singapore launch at the Supreme Court Terrace, National Gallery Singapore, bringing medicine, fashion and culture into a conversation about contemporary beauty. Set within one of Singapore's defining cultural landmarks, the evening brought art and science into dialogue to explore contemporary ideas of beauty, individuality and wellbeing.

      Continue Reading
      Löviselle
      Löviselle
      (Top) Kelvin Toh, COO, APAC Sinobiom (Bottom) Dr Zhuang Xiuli, Director and General Manager of Sinobiom
      (Top) Kelvin Toh, COO, APAC Sinobiom (Bottom) Dr Zhuang Xiuli, Director and General Manager of Sinobiom
      (Top) Dr Wang Ye (Bottom) Dr Liang Chong Guo
      (Top) Dr Wang Ye (Bottom) Dr Liang Chong Guo
      From left to right: Kevin Chong, Moderator; Cheryl Lai-Lim, Deputy Editor, GRAZIA Singapore; Tasha Low, Singer and Actress; Dr Lum Yang Xi; and Dr Heng Wee Soon.
      From left to right: Kevin Chong, Moderator; Cheryl Lai-Lim, Deputy Editor, GRAZIA Singapore; Tasha Low, Singer and Actress; Dr Lum Yang Xi; and Dr Heng Wee Soon.

      Held under the theme "Beyond Stimulation, True Regeneration," the launch welcomed more than 60 Singapore-based doctors and representatives from multiple media outlets. Attendees included Dr Zhuang Xiuli, Director and General Manager of Sinobiom; Kelvin Toh, COO, APAC Sinobiom; Rocky Xu, Brand Director of Sinobiom; Dr Cui Li Guo, R&D and Medical Director of Sinobiom; medical speakers Dr Wang Ye and Dr Liang Chong Guo; Singapore aesthetic doctors Dr Lum Yang Xi and Dr Heng Wee Soon; Singaporean actress and singer Tasha Low; and Cheryl Lai-Lim, Deputy Editor of GRAZIA Singapore. The programme introduced LÖVISELLE's Bio-Active Regeneration approach and its philosophy of "Natural Regeneration, Natural Expression."

      Dr Zhuang, who spent more than three decades conducting research at the Chinese Academy of Sciences, traced the product's scientific origins. Development began in 2011, drawing on expertise in orthopedics and absorbable implants, drug targeting and sustained-release delivery. Following years of foundational research, the product entered clinical trials in 2018 and received approval in China in 2021. According to Sinobiom, more than one million people have received treatment with the product, which has been used by approximately 7,200 doctors at over 4,000 institutions.

      Dr Zhuang reaffirmed LÖVISELLE's long-term commitment to Singapore through sustained investment in clinical support and research, medical training, patient education and brand development. Working alongside local doctors, clinics and partners, the brand aims to build lasting relationships grounded in safety, efficacy and trust. This commitment reflects the brand's conviction that the pursuit of beauty today should never come at the expense of future health and well-being.

      In "LÖVISELLE: The Kaleidoscope," Dr Wang Ye, an experienced aesthetic physician and international speaker with a PhD in Surgery, explored natural rejuvenation through his clinical work in facial injectables and experience training doctors worldwide. He presented LÖVISELLE's smooth microsphere design and the brand's anti-inflammatory approach to regeneration. His clinical cases showed how one material, tailored to different faces, needs and aesthetic preferences, could achieve varied improvements. He emphasised the importance of skin quality and firmness, highlighting LÖVISELLE's possibilities beyond volume enhancement.

      Dr Liang Chong Guo, founder and owner of Laser Beauty Clinic and a member of the American Society of Facial Plastic Surgery, explored the relationship between clinical value and sustainable clinic growth in "From Syringe to Scale." Drawing on his experience as both a doctor and an entrepreneur, he described how his clinic integrated LÖVISELLE into treatment planning, team training, patient communication and follow-up. He highlighted the role of natural, progressive results and patient trust in encouraging repeat visits, referrals and lasting relationships. Long-term commitment, in his view, provides a foundation for both patient care and sustainable clinic growth.

      The roundtable, "A Regenerative Approach to Ageing: Health, Aesthetics and Lifestyle," connected clinical perspectives with personal experiences of beauty. Singaporean actress and singer Tasha Low, a former member of K-pop group SKarf and a lead actress in Emerald Hill – The Little Nyonya Story, reflected on whether beauty choices come from personal wishes or pressure to meet external expectations. Working in entertainment and navigating social media had taught her to make those choices for herself. This informed her understanding of "Still Me But Better": enjoying different looks while preserving the qualities that make her recognisably herself. "Because of my job, I get to experiment with so many different looks, which is always fun! But at the end of the day, I still want to look in the mirror and recognise myself," she said.

      GRAZIA Singapore Deputy Editor Cheryl Lai-Lim described a growing appreciation of distinctive features and personal identity. She argued that enhancing one's appearance and embracing individuality can go hand in hand. From her editorial perspective, beauty enhancement and individuality can coexist, with informed choices allowing people to define beauty on their own terms.

      Singapore aesthetic doctor Dr Lum Yang Xi explained how persistent, low-grade inflammation can interfere with repair and contribute to ageing. Fellow aesthetic doctor Dr Heng Wee Soon advocated supporting regeneration while limiting unnecessary inflammation, linking treatment choices with long-term skin health. His guiding principle was that more regeneration and less inflammation over time support lasting beauty.

      The Singapore launch marks a new milestone in LÖVISELLE's expansion across Asia-Pacific. Looking ahead, Kelvin Toh, COO, APAC Sinobiom, outlined three commitments: education and clinical exchange, accessible local support, and lasting relationships with doctors and clinics. "We know trust takes time. We hope to earn yours by communicating clearly and being there when you need us," he said. Together with Singapore's medical community, LÖVISELLE aims to build its next chapter in regenerative aesthetics.

      SOURCE Löviselle

      Modal title

      Also from this source

      Löviselle LEAP Advances Across Singapore and Malaysia: Building a Regional Platform for Bio-Active Regeneration

      Löviselle LEAP Advances Across Singapore and Malaysia: Building a Regional Platform for Bio-Active Regeneration

      Following the inaugural LEAP at a leading Singapore Medical Academy, Löviselle convened the first Malaysian LEAP at the Medical Academy of Malaysia....

      More Releases From This Source

      Explore

      Cosmetics and Personal Care

      Cosmetics and Personal Care

      Health Care & Hospitals

      Health Care & Hospitals

      Household, Consumer & Cosmetics

      Household, Consumer & Cosmetics

      Supplementary Medicine

      Supplementary Medicine

      News Releases in Similar Topics

      Contact PR Newswire

      • General Inquiries
      • Request a Demo
      • Partnerships
      • Media Inquiries

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Become a Publishing Partner
      • Careers
      • Accessibility Statement
      • APAC – Simplified Chinese
      • APAC
      • APAC - Traditional Chinese
      • Arabic
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • United States
      • Vietnam

      My Services

      • All New Releases
      • Platform

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact Cision

      Products

      About

      My Services
      • All News Releases
      • Platform
      [email protected]
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookie Settings
      • Accessibility
      Copyright © 2026 Cision US Inc.